IP Library Granted Patent US 8,580,771
Granted Patent B2
US 8,580,771 · App. 11/244,974 · Granted Nov 12, 2013

Dosage form for hormonal contraception

Inventors: Georg Schramm (Stolberg, DE); Eric-Paul Paques (Aachen, DE)
Assignee: Richter Gedeon Nyrt.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,771
App. No.
11/244,974
Granted
Nov 12, 2013
Kind
B2
Abstract

A dosage form for hormonal contraception containing a given number of hormone-containing daily units and a given number of hormone-free daily units for daily, oral administration, where the hormone-containing daily units each contain at most the minimum effective daily amount of folic acid for women and the hormone-free daily units contain at least a multiple of this amount up to the maximum permissible amount of folic acid for women.

Claims (13)

1. A hormonal contraceptive dosage form for uninterrupted daily oral administration to women, said dosage form comprising hormone-containing daily units and hormone-free daily units, wherein each of the hormone-containing daily units comprises folic acid in a daily amount of from between about 5 to 200 μg and a combination of an oestrogen and a gestagen, and each of the hormone-free daily units comprises folic acid in a daily amount of greater than 200 μg up to the maximum permissible amount of folic acid for women.

2. A dosage form according to claim 1 , wherein the hormone-free daily units each comprises more than 200 μg and up to 5 mg of folic acid.

3. A dosage form according to claim 1 , wherein the hormone-containing daily units each comprises the same amount of folic acid and the hormone-free daily units likewise each comprises the same amount of folic acid.

4. A dosage form according to claim 1 , wherein the dosage form comprises at least 21 hormone-containing daily units and 7 to 3 hormone-free daily units.

5. A dosage form according to claim 4 , wherein the number of hormone-containing daily units is sufficient for administration for a maximum of 2 years, and the number of hormone-free daily units is sufficient for administration for to 7 to 3 days.

6. A dosage form according to claim 4 , comprising up to 730 hormone-containing daily units and 7 to 3 hormone-free daily units.

7. A dosage form according to claim 4 , which comprises 21 to 25 hormone-containing daily units and 7 to 3 hormone-free daily units.

8. A dosage form according to claim 4 , which comprises 42 to 52 hormone-containing daily units and 7 to 3 hormone-free daily units.

9. A dosage form according to claim 4 , which comprises 77 to 193 hormone-containing daily units and 7 to 3 hormone-free daily units.

10. A dosage form according to claim 1 , wherein the number of hormone-containing daily units corresponds to a monophasic contraceptive.

11. A kit comprising at least one dosage form for hormonal contraception according to claim 1 .

12. A kit according to claim 11 , wherein the kit comprises a plurality of dosage forms.

13. A dosage form according to claim 6 , wherein the dosage form comprises up to 365 hormone-containing daily units and 7 to 3 hormone-free daily units.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: GRUNENTHAL GMBH
To: RICHTER GEDEON NYRT.
Reel/Frame 028229/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2006
From: SCHRAMM, GEORG; PAQUES, ERIC-PAUL
To: GRUNENTHAL GMBH
Reel/Frame 017498/0523 →
Priority Claims (2)
DE 10 2004 026 670 · May 28, 2004 · national
DE 10 2004 026 671 · May 28, 2004 · national
Continuity (3)
Continuation In Part 11009817 · Dec 10, 2004
Continuation In Part 11009938 · Dec 10, 2004
Related Publication 20060089338A1 · Apr 27, 2006